A novel arylethynyltriazole acyclonucleoside inhibits proliferation of drug-resistant pancreatic cancer cells
β Scribed by Menghua Wang; Yi Xia; Yuting Fan; Palma Rocchi; Fanqi Qu; Juan L. Iovanna; Ling Peng
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 767 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
β¦ Synopsis
Novel arylethynyltriazole acyclonucleosides were synthesized and assessed for their anticancer activity on drug-resistant pancreatic cancer MiaPaCa-2 cells. One lead compound was found to have much more potent apoptosis-related antiproliferative effects than gemcitabine, the current first-line treatment for pancreatic cancer. Further investigations showed that this active compound did not inhibit DNA synthesis, which means that it does not resemble gemcitabine and may involve a different mechanism of action.
π SIMILAR VOLUMES
AR4-2J, a rat pancreatic acinar-tumor cell line, was used to investigate long-term effects of basic fibroblast growth factor (bFGF) and somatostatin on pancreatic cancer cells. We observed that bFGF stimulated cell proliferation when cells were cultured in serum-free medium. The effect was dose-depe
## Abstract During our search for cancer chemopreventing compounds derived from plant sources, we discovered that the natural product GUTβ70, isolated from the stem bark of __Calophyllum brasiliense__ collected in Brazil, significantly inhibits the growth of leukemic cells. GUTβ70, characterized as